|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/12/19 Biolase, Inc 10-Q 9/30/19 86:10M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 792K
7: EX-4.8 Instrument Defining the Rights of Security Holders HTML 95K
2: EX-10.5 Material Contract HTML 55K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
54: R1 Document and Entity Information HTML 78K
32: R2 Consolidated Balance Sheets (Unaudited) HTML 111K
39: R3 Consolidated Balance Sheets (Unaudited) HTML 47K
(Parenthetical)
83: R4 Consolidated Statements Of Operations And HTML 97K
Comprehensive Loss (Unaudited)
52: R5 Consolidated Statements of Stockholders' (Deficit) HTML 58K
Equity (Unaudited)
31: R6 Consolidated Statements Of Cash Flows (Unaudited) HTML 134K
38: R7 Description of Business and Basis of Presentation HTML 42K
81: R8 Summary of Significant Accounting Policies HTML 40K
55: R9 Revenue Recognition HTML 215K
48: R10 Stockholders' (Deficit) Equity HTML 300K
21: R11 Inventory HTML 46K
64: R12 Property, Plant, and Equipment HTML 67K
73: R13 Intangible Assets and Goodwill HTML 29K
47: R14 Accrued Liabilities HTML 117K
20: R15 Debt HTML 103K
63: R16 Leases HTML 74K
72: R17 Commitments and Contingencies HTML 34K
46: R18 Segment Information HTML 75K
22: R19 Concentrations HTML 114K
50: R20 Income Taxes HTML 31K
79: R21 Subsequent Events HTML 36K
34: R22 Summary of Significant Accounting Policies HTML 77K
(Policies)
24: R23 Revenue Recognition (Tables) HTML 296K
49: R24 Stockholders' (Deficit) Equity (Tables) HTML 304K
78: R25 Inventory (Tables) HTML 47K
33: R26 Property, Plant, and Equipment (Tables) HTML 66K
23: R27 Accrued Liabilities (Tables) HTML 118K
51: R28 Debt (Tables) HTML 79K
77: R29 Leases (Tables) HTML 75K
74: R30 Segment Information (Tables) HTML 76K
66: R31 Concentrations (Tables) HTML 166K
18: R32 Description of Business and Basis of Presentation HTML 69K
- Additional Information (Detail)
44: R33 Summary of Significant Accounting Policies - HTML 36K
Additional Information (Detail)
75: R34 Revenue Recognition - Additional Information HTML 38K
(Detail)
67: R35 Summary of Opening and Closing Balances of HTML 36K
Contract Liabilities (Detail)
19: R36 Summary of Disaggregation of Revenues Related to HTML 32K
Geographic Areas (Detail)
45: R37 Summary of Revenues Disaggregated by Timing of HTML 33K
Goods and Services Transferred (Detail)
76: R38 Summary of Sales by End Market (Detail) HTML 33K
65: R39 Summary of Percentages of Sales by Product line HTML 40K
(Detail)
80: R40 Stockholders' (Deficit) Equity - Additional HTML 84K
Information (Detail)
56: R41 Classification of Compensation Expense Associated HTML 38K
with Share-Based Payments (Detail)
29: R42 Assumptions Used in Estimating Fair Value of Stock HTML 34K
Options Granted (Detail)
40: R43 Summary of Option Activity (Detail) HTML 65K
82: R44 Summary of Unvested Stock Option Activity (Detail) HTML 47K
57: R45 Cash Proceeds Along with Fair Value Disclosures HTML 33K
Related to Grants, Exercises and Vested Options
(Detail)
30: R46 Summary of Unvested Restricted Stock Units HTML 50K
(Detail)
41: R47 Summary of Warrant Activity (Detail) HTML 43K
84: R48 Components of Inventory (Detail) HTML 35K
53: R49 Inventory - Additional Information (Detail) HTML 28K
61: R50 Summary of Property, Plant, and Equipment (Detail) HTML 49K
70: R51 Property, Plant, and Equipment - Additional HTML 28K
Information (Detail)
43: R52 Intangible Assets and Goodwill - Additional HTML 34K
Information (Detail)
17: R53 Components of Accrued Liabilities (Detail) HTML 52K
60: R54 Changes in Initial Product Warranty Accrual and HTML 41K
Expenses Under Initial and Extended Warranties
(Detail)
69: R55 Accrued Liabilities - Additional Information HTML 33K
(Detail)
42: R56 Debt - Summary of Principal Outstanding and HTML 33K
Unamortized Discount (Detail)
16: R57 Debt - Additional Information (Detail) HTML 209K
62: R58 Debt - Summary of Future Minimum Principal and HTML 49K
Interest Payments (Detail)
68: R59 Leases - Additional Information (Detail) HTML 59K
37: R60 Leases - Information related to Right-of-use HTML 34K
Assets and Liabilities (Detail)
27: R61 Leases - Schedule of Maturities of Lease HTML 39K
Liabilities (Detail)
59: R62 Leases - Future Minimum Rental Commitments Under HTML 35K
Lease Agreements (Detail)
86: R63 Commitments and Contingencies - Additional HTML 56K
Information (Detail)
36: R64 Segment Information - Additional Information HTML 39K
(Detail)
26: R65 Summary of Net Revenue by Geographic Location HTML 32K
(Detail)
58: R66 Summary of Property, Plant and Equipment by HTML 33K
Geographic Location (Detail)
85: R67 Concentrations - Summary of Net Revenue from HTML 51K
Various Products (Detail)
35: R68 Concentrations - Additional Information (Detail) HTML 41K
28: R69 Income Taxes - Additional Information (Detail) HTML 37K
15: R70 Subsequent Events - Additional Information HTML 88K
(Detail)
14: XML IDEA XML File -- Filing Summary XML 153K
71: EXCEL IDEA Workbook of Financial Reports XLSX 91K
8: EX-101.INS XBRL Instance -- biol-20190930 XML 2.79M
10: EX-101.CAL XBRL Calculations -- biol-20190930_cal XML 170K
11: EX-101.DEF XBRL Definitions -- biol-20190930_def XML 583K
12: EX-101.LAB XBRL Labels -- biol-20190930_lab XML 1.39M
13: EX-101.PRE XBRL Presentations -- biol-20190930_pre XML 1.06M
9: EX-101.SCH XBRL Schema -- biol-20190930 XSD 215K
25: ZIP XBRL Zipped Folder -- 0001564590-19-042402-xbrl Zip 178K
Exhibit 31.2
CERTIFICATION
I, John R. Beaver, certify that:
|
1. |
I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2019 of BIOLASE, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Date: November 8, 2019 |
By: |
/s/ JOHN R. BEAVER |
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 11/12/19 | |||
| Filed on: | 11/8/19 | |||
| For Period end: | 9/30/19 | 8-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/03/23 Biolase, Inc. S-1/A 6:1M Donnelley … Solutions/FA 12/12/22 Biolase, Inc. S-1/A 7:1.1M Donnelley … Solutions/FA 11/22/22 Biolase, Inc. S-1 3:655K Donnelley … Solutions/FA 3/17/22 Biolase, Inc. 10-K 12/31/21 88:18M Donnelley … Solutions/FA 11/10/21 Biolase, Inc. 10-Q 9/30/21 84:13M Donnelley … Solutions/FA 8/13/21 Biolase, Inc. 10-Q 6/30/21 80:12M Donnelley … Solutions/FA 5/13/21 Biolase, Inc. 10-Q 3/31/21 81:9.4M Donnelley … Solutions/FA 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA 11/13/20 Biolase, Inc. 10-Q 9/30/20 81:11M ActiveDisclosure/FA 8/14/20 Biolase, Inc. 10-Q 6/30/20 89:12M ActiveDisclosure/FA |